XML 42 R35.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Joint Venture (Tables)
9 Months Ended
Mar. 31, 2024
Equity Method Investments and Joint Ventures [Abstract]  
Summary of Reconciliation Between the Carrying Value of Investment and Proportional Share of Underlying Equity in Net Assets of Joint Ventures

The following table shows the reconciliation between the carrying value of the Company's investment in the JV and its proportional share of the underlying equity in net assets of the JV (in thousands):

 

 

 

March 31,
2024

 

 

June 30,
2023

 

Carrying value of investment in joint venture

 

$

13,586

 

 

$

15,128

 

Deferred intra-entity profit margin

 

 

7,893

 

 

 

5,737

 

Equity method goodwill

 

 

(4,720

)

 

 

(4,720

)

Proportional share of equity investment in joint venture

 

$

16,759

 

 

$

16,145

 

 

Summary of Financial Information of Joint Ventures (Operations Data)

Summarized financial information of the JV is as follows (in thousands):

 

 

 

Three Months Ended
December 31,

 

 

Nine Months Ended
December 31,

 

Statement of Operations Data:

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Revenue

 

$

45,173

 

 

$

36,831

 

 

$

99,485

 

 

$

87,554

 

Gross profit

 

 

7,401

 

 

 

6,931

 

 

 

16,014

 

 

 

15,246

 

Net income

 

 

2,091

 

 

 

4,159

 

 

 

2,098

 

 

 

1,991

 

Net income attributable to the Company

 

 

1,024

 

 

 

2,027

 

 

 

1,028

 

 

 

960

 

Summary of Financial Information of Joint Ventures (Balance Sheet Data)

Summarized Balance Sheet Data:

 

As of
December 31, 2023

 

 

As of
December 31, 2022

 

Assets

 

 

 

 

 

 

Current assets

 

$

107,893

 

 

$

88,010

 

Non-current assets

 

 

13,417

 

 

 

17,364

 

Total assets

 

$

121,310

 

 

$

105,374

 

Liabilities and Stockholders' Equity

 

 

 

 

 

 

Current liabilities

 

$

86,554

 

 

$

74,990

 

Non-current liabilities

 

 

134

 

 

 

547

 

Stockholders' equity

 

 

34,622

 

 

 

29,837

 

Total liabilities and stockholders' equity

 

$

121,310

 

 

$

105,374

 

Schedule of Net Revenue Recognized From Intra Entity Profit Margin

The following table shows the activity of the Company’s net revenue recognized from intra-entity profit margin from sales (in thousands):

 

 

 

Three Months Ended
March 31,

 

 

Nine Months Ended
March 31,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Sales recognized from released deferred intra-entity profit margin

 

$

662

 

 

$

1,071

 

 

$

6,975

 

 

$

7,486

 

Deferred intra-entity profit margin from sales

 

 

(3,112

)

 

 

(3,390

)

 

 

(9,131

)

 

 

(8,819

)

Net revenue deferred from intra-entity profit margin from sales (1)

 

$

(2,450

)

 

$

(2,319

)

 

$

(2,156

)

 

$

(1,333

)

 

(1)
Profit earned by the Company from the JV is eliminated through cost of goods sold until it is realized; such profits would generally be considered realized when the inventory has been sold through to third parties.